Walleye Trading LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$39,269,271
-3.7%
385,522
-4.6%
0.10%
-15.6%
Q2 2023$40,767,640
-25.0%
404,000
-31.6%
0.12%
+3.4%
Q1 2023$54,335,200
+5.0%
590,600
+3.5%
0.12%
-19.7%
Q4 2022$51,755,760
+70.4%
570,500
+42.8%
0.15%
+59.8%
Q3 2022$30,366,000
+151.4%
399,500
+179.6%
0.09%
+135.9%
Q2 2022$12,079,000
-37.1%
142,900
-34.7%
0.04%
-37.1%
Q1 2022$19,191,000
-43.1%
218,700
-43.3%
0.06%
-44.1%
Q4 2021$33,755,000
+178.0%
385,900
+159.9%
0.11%
+152.3%
Q3 2021$12,144,000
+1144.3%
148,500
+1287.9%
0.04%
+1000.0%
Q2 2021$976,000
-9.4%
10,700
-15.1%
0.00%
-20.0%
Q1 2021$1,077,000
-87.9%
12,600
-86.6%
0.01%
-87.2%
Q4 2020$8,877,000
+19.0%
94,000
+9.6%
0.04%
-2.5%
Q3 2020$7,461,000
+399.4%
85,800
+401.8%
0.04%
+344.4%
Q2 2020$1,494,000
-57.0%
17,100
-59.4%
0.01%
-66.7%
Q1 2020$3,474,000
-60.1%
42,144
-54.2%
0.03%
-55.7%
Q4 2019$8,712,000
+42.2%
92,000
+30.5%
0.06%
+17.3%
Q3 2019$6,126,000
+92.8%
70,500
+102.6%
0.05%
+92.6%
Q2 2019$3,178,000
+16.4%
34,800
+22.5%
0.03%
+28.6%
Q1 2019$2,730,000
-13.5%
28,400
-22.8%
0.02%
-12.5%
Q4 2018$3,157,000
-5.9%
36,800
-5.5%
0.02%
+33.3%
Q3 2018$3,355,000
+177.3%
38,927
+143.1%
0.02%
+157.1%
Q2 2018$1,210,000
-38.0%
16,016
-33.6%
0.01%
-36.4%
Q1 2018$1,951,000
-27.4%
24,127
-24.6%
0.01%
-15.4%
Q4 2017$2,686,000
-68.5%
32,000
-67.8%
0.01%
-69.0%
Q3 2017$8,532,000
+48.6%
99,342
+44.4%
0.04%
+20.0%
Q2 2017$5,743,000
-25.5%
68,800
-33.7%
0.04%
-35.2%
Q1 2017$7,711,000
+128.6%
103,824
+124.2%
0.05%
+125.0%
Q4 2016$3,373,000
-21.4%
46,300
-14.8%
0.02%
-14.3%
Q3 2016$4,293,000
+56.4%
54,359
+63.7%
0.03%
+55.6%
Q2 2016$2,745,000
-7.4%
33,200
-18.9%
0.02%
-33.3%
Q1 2016$2,963,000
-24.4%
40,933
-10.2%
0.03%
-28.9%
Q4 2015$3,921,000
+38.6%
45,585
+48.1%
0.04%
+52.0%
Q3 2015$2,829,000
+29.4%
30,773
+38.5%
0.02%
+19.0%
Q2 2015$2,186,000
-25.1%
22,218
-24.9%
0.02%
-25.0%
Q1 2015$2,918,000
+15.8%
29,571
+8.7%
0.03%
+21.7%
Q4 2014$2,520,000
+1.0%
27,200
+2.6%
0.02%
-23.3%
Q3 2014$2,495,000
+41.4%
26,500
+35.9%
0.03%
+25.0%
Q2 2014$1,764,000
+9.4%
19,500
+3.2%
0.02%
+4.3%
Q1 2014$1,612,000
-16.1%
18,900
-20.9%
0.02%
+21.1%
Q4 2013$1,921,000
+578.8%
23,900
+545.9%
0.02%
+850.0%
Q3 2013$283,000
-91.1%
3,700
-91.8%
0.00%
-93.3%
Q2 2013$3,196,00045,2000.03%
Other shareholders
NOVARTIS A G shareholders Q1 2018
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders